To investigate this possibility, we assessed mRNA expression for BIM, BID, PUMA, HRK, BAD and BCL-XL in newly diagnosed chronic phase CML patients. The gene discussed is BAD; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.